Strategies for therapeutic targeting of the p53 pathway in cancer
Author:
- 24 March 2006
- journal article
- review article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 13 (6) , 921-926
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Regulation of p53 DNA Binding2007
- Prognostic and Predictive Value of TP53 Mutations in Human Cancer2007
- Heat shock phenocopies E1B-55K late functions and selectively sensitizes refractory tumor cells to ONYX-015 oncolytic viral therapyCancer Cell, 2005
- A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in HumansCell, 2004
- The IARC TP53 database: New online mutation analysis and recommendations to usersHuman Mutation, 2002
- Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trialGene Therapy, 2001
- Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung CancerJNCI: Journal of the National Cancer Institute, 1999
- Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation DomainScience, 1996
- An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor CellsScience, 1996
- Amplification of a gene encoding a p53-associated protein in human sarcomasNature, 1992